Key facts
- It has raised $200.0M; the latest was Later Stage VC ($200.0M) in Mar 2026.
- Notable investors include Joseph Lonsdale, Antonio Gracias, Aon, Ara Cohen, Jeffrey Aronin — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for eMed (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for eMed (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About eMed (Clinics/Outpatient Services)
Developer of a clinician-led GLP-1 care program designed to support weight management and long-term health improvement. The company offers at-home blood testing, personalized care plans, clinician-guided medication management, side-effect support, progress tracking tools, and an integrated digital platform, enabling individuals and employers to manage weight and related health indicators with continuous medical oversight and sustained lifestyle adherence.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Employees
- 256
- Website
- emed.com/
- Ownership
- Privately Held (backing)
eMed (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in eMed (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on eMed (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.